Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-001932

Director bought 5,000 shares at an average $25.43 ($127,129)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Sigal Charles Elliott Director 2023-01-03 Purchase +2,500 $25.60 $63,993 2,500 I
Sigal Charles Elliott Director 2023-01-04 Purchase +2,500 $25.25 $63,136 5,000 I
Open-market purchases · 5,000 sh · avg $25.43 · $127,129
Loading xslF345X03/doc4.xml…